8. The Adjuvanted Recombinant Zoster Vaccine (RZV) Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study (ZOSTER-049) of Two Clinical Trials (ZOE-50 and ZOE-70)
8. 佐剂重组带状疱疹疫苗 (RZV) 可提供针对带状疱疹的长期保护:两项临床试验 (ZOE-50 和 ZOE-70) 的扩展研究 (ZOSTER-049) 的中期结果
期刊:Diseases of the Colon & Rectum
影响因子:3.7
doi:10.1097/DCR.0000000000001684
Rumer, Kristen K; Dehghan, Melody S; Sceats, Lindsay A; Trickey, Amber W; Morris, Arden M; Kin, Cindy; Rapaka, Rekha R; Workneh, Meklit; Bollman, Brooke A; Rumyantsev, Alexander; Schoofs, Till; Oostendorp, Jaap; Fortier, Gabrielle; Mancini, Kevin; Yuan, Wenlin; Bailey, Lauren; Bartholomew, Tin; McGrath, Shannon; Cahill, Heather L; Buchanan, Agi; Carlson, Katherine B; Schrantz, Stephen J Jr; Fink, Doran; Boutry, Céline; Hastie, Andrew; Shi, Meng; Diez-Domingo, Javier; Tinoco, Juan Carlos; Yu, Chong-Jen; Pirrotta, Paola; Kalema, George; Schuind, Anne